iiinova — where your digital self keeps evolving

James O’Donnell

@jsodonnell.bsky.social

Reposted by James O’Donnell

RCSI University of Medicine and Health Sciences @rcsi.bsky.social · 25/05/2026

Prof James O’Donnell has secured €2m from @researchireland.ie and the Irish Blood Transfusion Service for a new four-year research programme. The study will examine how differences between blood groups influence the body’s ability to regulate bleeding 🔗 www.rcsi.com/dublin/news-... #RCSIdiscover

rcsi.com

Professor James O’Donnell to lead €2m national study on blood groups and bleeding disorders

RCSI’s Professor James O’Donnell has secured €2 million in funding from Research Ireland and the Irish Blood Transfusion Service. More ...

032

Reposted by James O’Donnell

Blood Journals Portfolio @bloodjournals.hematology.org · 18/07/2025

Low VWF–QL is a distinct clinicopathological entity compared with type 2 VWD. buff.ly/X35uyr5 #hemesky

042

Reposted by James O’Donnell

RCSI University of Medicine and Health Sciences @rcsi.bsky.social · 10/03/2025

According to new RCSI research, immune cells that 'remember' past inflammation could increase the risk of blood clots in the long term. The 'shortened fuse' in these cells may contribute to a higher blood clot risk in inflammatory conditions. Read more 🔗 www.rcsi.com/dublin/news-... #RCSIdiscover

A man (Prof Roger Preston) with short, light brown hair stands in a modern, glass-walled corridor with a skylight ceiling. He is wearing a dark grey suit, a light blue striped shirt, and a dark blue tie. He has a confident expression with a slight smile and his arms crossed. The background features a contemporary interior design with glass partitions, metal framing, and a curved black railing leading down a staircase.

073

Reposted by James O’Donnell

RCSI University of Medicine and Health Sciences @rcsi.bsky.social · 21/02/2025

New RCSI research has uncovered how T cells may contribute to blood clot risk in inflammatory bowel disease. The findings, published in @NatureComms also suggest a potential treatment approach to manage this risk. Read more 🔗 www.rcsi.com/dublin/news-... #RCSIdiscover @rcsi-research.bsky.social

rcsi.com

New RCSI research identifies key role of T cells in blood clot risk for inflammatory bowel disease patients

Researchers from RCSI University of Medicine and Health Sciences have uncovered a novel mechanism linking inflammatory bowel disease (IBD) with an increased risk of a serious blood clotting disorder, ...

072

Reposted by James O’Donnell

ProfMakris @profmakris.bsky.social · 29/11/2024

Really good article in @jthjournal.bsky.social about how to deal with persons who have von Willebrand factor levels of 30-50%. The key is how "significant bleeding phenotype" is defined. tinyurl.com/y55mwkj3 #willebrand #VWD

0114